|
|
|
 |
FDA Approval Activities for this Drug…
BENDROFLUMETHIAZIDE; NADOLOL Tablet; 5MG;40MG CORZIDE KING 018647 BENDROFLUMETHIAZIDE; NADOLOL Tablet; 5MG;80MG CORZIDE KING 018063 NADOLOL Tablet; 120MG CORGARD APOTHECON 018063 NADOLOL Tablet; 160MG CORGARD APOTHECON 018063 NADOLOL Tablet; 20MG CORGARD APOTHECON 018063 NADOLOL Tablet; 40MG CORGARD APOTHECON 018063 NADOLOL Tablet; 80MG CORGARD APOTHECON 074368 NADOLOL Tablet; 120MG NADOLOL Copley 074368 NADOLOL Tablet; 160MG NADOLOL Copley 074368 NADOLOL Tablet; 80MG NADOLOL Copley 074501 NADOLOL Tablet; 20MG NADOLOL Geneva TECH 074501 NADOLOL Tablet; 40MG NADOLOL Geneva TECH 074501 NADOLOL Tablet; 80MG NADOLOL Geneva TECH 074255 NADOLOL Tablet; 120MG NADOLOL Ivax 074255 NADOLOL Tablet; 160MG NADOLOL Ivax 074229 NADOLOL Tablet; 20MG NADOLOL Ivax 074229 NADOLOL Tablet; 40MG NADOLOL Ivax 074255 NADOLOL Tablet; 80MG NADOLOL Ivax 074172 NADOLOL Tablet; 20MG NADOLOL Mylan 074172 NADOLOL Tablet; 40MG NADOLOL Mylan 074172 NADOLOL Tablet; 80MG NADOLOL Mylan | Nadolol/Bendroflumethiazide Tablets, Impax Labs, Approval | Corgard (nadolol) Tablets, King Pharma, Labeling Revision | Nadolol and Bendroflumethiazide Tablets, Mylan Pharma, Approval | Corzide (bendroflumethiazide and nadolol) Tablets, King Pharmaceuticals, Labeling Revision | Corgard (nadolol) Tablets, King Pharmaceuticals Inc., Labeling Revision | Corzide (bendroflumethiazide and nadolol) Tablets, Pfizer, Inc., Labeling Revision
  
|